Renalytix plc (RNLXY) stock
RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)
Close on Oct 19, 2026Market cap $375.75MP/E –Yield –
Renalytix EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Renalytix's EPS for the twelve months ending Sep 30, 2024 was -$0.26. For fiscal 2024 it was -$0.31. The highest annual figure on record is -$0.17 in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Jun 30, 2024 | -$0.31 | – |
| FY2023 | Jun 30, 2023 | -$0.55 | – |
| FY2022 | Jun 30, 2022 | -$0.67 | – |
| FY2021 | Jun 30, 2021 | -$0.49 | – |
| FY2020 | Jun 30, 2020 | -$0.17 | – |
| FY2019 | Jun 30, 2019 | -$0.99 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$0.04 | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$0.05 | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$0.08 | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$0.09 | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$0.11 | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$0.12 | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$0.14 | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$0.14 | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$0.16 | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$0.07 | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$0.20 | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$0.21 | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$0.14 | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$0.14 | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$0.12 | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$0.12 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?